iRhythm Holdings (IRTC) Non-Current Assets (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Non-Current Assets came in at $325.8 million in Q1 2026, up 12.31% year-on-year from $290.1 million in Q1 2025, and up 2.69% on a QoQ basis from $317.3 million in Q4 2025.
iRhythm Holdings (IRTC) Non-Current Assets (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Non-Current Assets data on file, last reported at $325.8 million in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 12.31% year-over-year to $325.8 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 14.48% increase from a year earlier, with the FY2025 full-year figure at $317.3 million, up 11.08% from the prior year.
- Non-Current Assets for Q1 2026 stood at $325.8 million, up from $317.3 million in the prior quarter.
- Over the last five years, Non-Current Assets for IRTC reached as high as $325.8 million in Q1 2026 and fell as low as $142.4 million in Q1 2022.
- Historically, Non-Current Assets has averaged $232.4 million across 5 years, with a median of $222.3 million in 2024.
- Across the five-year window, Non-Current Assets declined 0.34% in 2022 and surged 41.17% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $159.4 million in 2022, then climbed by 26.89% to $202.3 million in 2023, then surged by 41.17% to $285.6 million in 2024, then increased by 11.08% to $317.3 million in 2025, then advanced by 2.69% to $325.8 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $325.8 million in Q1 2026, $317.3 million in Q4 2025, and $315.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | 325.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.81 Mn |
| Dec 31, 2025 | 317.28 Mn |
| Sep 30, 2025 | 315.18 Mn |
| Jun 30, 2025 | 300.11 Mn |
| Mar 31, 2025 | 290.09 Mn |
| Dec 31, 2024 | 285.63 Mn |
| Sep 30, 2024 | 281.78 Mn |
| Jun 30, 2024 | 241.68 Mn |
| Mar 31, 2024 | 222.30 Mn |
| Dec 31, 2023 | 202.33 Mn |
| Sep 30, 2023 | 205.48 Mn |
| Jun 30, 2023 | 187.35 Mn |
| Mar 31, 2023 | 167.81 Mn |
| Dec 31, 2022 | 159.45 Mn |
| Sep 30, 2022 | 154.54 Mn |
| Jun 30, 2022 | 150.87 Mn |
| Mar 31, 2022 | 142.36 Mn |
| Dec 31, 2021 | 157.45 Mn |
| Sep 30, 2021 | 155.06 Mn |
| Jun 30, 2021 | 149.66 Mn |